TuisD4S • FRA
add
Daiichi Sankyo Co Ltd
Vorige sluiting
€18,85
Dagwisseling
€19,29 - €19,29
Jaarwisseling
€18,02 - €31,68
Markkapitalisasie
6,68 bn JPY
Gemiddelde volume
120,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
TYO
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (JPY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 500,76 mjd | 12,14% |
Bedryfskoste | 297,25 mjd | 16,75% |
Netto inkomste | 45,31 mjd | -26,07% |
Netto winsgrens | 9,05 | -34,09% |
Wins per aandeel | — | — |
EBITDA | 66,41 mjd | -39,95% |
Effektiewe belastingkoers | 21,57% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (JPY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 542,16 mjd | -23,39% |
Totale bates | 3,57 bn | 8,25% |
Totale aanspreeklikheid | 1,92 bn | 14,47% |
Totale ekwiteit | 1,65 bn | — |
Uitstaande aandele | 1,85 mjd | — |
Prys om te bespreek | 0,02 | — |
Opbrengs op bates | 3,38% | — |
Opbrengs op kapitaal | 6,54% | — |
Kontantvloei
Netto kontantverandering
| (JPY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 45,31 mjd | -26,07% |
Kontant van bedrywe | 8,26 mjd | -75,35% |
Kontant van beleggings | -42,79 mjd | -293,67% |
Kontant van finansiering | -3,43 mjd | 95,63% |
Netto kontantverandering | -32,14 mjd | 67,07% |
Beskikbare kontantvloei | -839,12 m | -101,58% |
Meer oor
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
HUB
Gestig
1899
Hoofkwartier
Webwerf
Werknemers
19 765
